Bayer Aktiengesellschaft

€55.48As of Sun 8 Nov 2026, 12:00 UTC

XETRA:BAYNHealthcare

Country Germany

PE (Fwd) •••

TSR 10Y CAGR (2.02%)

Div yield 0.20%

ROE (4.56%)

Drug Manufacturers (General)

Beta (5Y) 0.81

PE TTM —

TSR TTM 106.45%

Mkt cap €54.50B

ROIC 11.99%

SE Grade™

—

Value

Quality

Moat

Consensus

Reference

€71

27.29%

(87.59%)

Sell 0|2|2|0|10

TTM

FYE 31 Dec EUR

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

5.593

Revenue€B

12.03

11.98

12.36

12.23

12.18

12.25

12.51

12.64

12.92

5.804

1.19%

1.08%

18.51

Revenue growth%

31.83

31.71

29.68

28.57

31.36

31.03

31.36

28.64

26.99

24.21

20.30

28.64

30.36

11.94

Gross margin%

21.19

22.99

20.10

19.99

22.46

23.29

23.74

22.75

24.04

22.69

2.53

23.29

22.72

20.92

Operating margin%

2.22

5.22

5.99

4.88

6.24

9.17

11.68

10.24

9.20

8.52

3.81

9.20

7.38

5.41

Net margin%

20.17

18.51

18.97

21.11

19.76

19.25

22.04

22.59

22.47

23.00

28.84

22.47

20.64

18.25

P/E ratio (avg)x

21.83

23.11

22.52

21.80

24.78

23.32

22.97

24.97

25.93

28.27

27.32

24.97

23.22

33.90

EV/EBITx

25.27

24.13

21.38

20.05

19.66

17.78

18.13

16.90

15.48

15.32

17.74

16.90

18.89

9.44

FCF yield (avg)%

13.89

15.83

14.62

14.14

14.04

13.55

11.01

11.73

10.01

12.60

12.15

11.73

13.72

4.69

FCF margin%

5.60

6.61

7.34

9.30

11.94

12.14

10.28

12.94

12.47

10.05

7.46

12.14

10.17

0.634

FCF / Net incomex

1.000

1.076

0.968

0.893

0.880

0.925

1.000

1.038

1.033

0.908

0.183

1.000

0.984

23.09

ROIC%

5.37

5.66

4.68

6.23

5.19

2.79

2.11

3.40

5.71

4.55

26.05

3.40

4.93

21.62

Return on equity%

32.91

29.98

30.33

28.01

29.22

29.72

31.53

31.08

30.32

30.09

10.91

30.32

30.20

14.79

Return on assets%

31.91

34.47

33.15

36.08

33.15

33.91

35.56

38.40

38.91

39.94

15.84

38.40

35.02

5.61

EPS€

1.97

2.14

2.16

2.32

2.26

2.29

2.34

2.32

2.23

2.50

5.97

2.00%

2.45%

—

28.82

EPS growth%

29.35

28.00

26.14

26.67

26.14

23.69

22.36

24.12

24.06

26.16

22.65

24.06

26.14

0.94

Bookvalue per sh€

3.04

3.22

3.82

4.50

5.20

6.04

6.56

7.08

6.96

8.06

3.05

9.15%

10.53%

—

2.18

FCF per share€

5.34

5.82

6.39

7.10

7.86

7.34

8.03

7.93

8.35

9.11

5.40

3.01%

6.00%

—

4.71

Dividend per sh€

1.30

1.42

1.46

1.55

1.58

1.50

1.58

1.70

1.74

1.91

2.41

3.86%

3.00%

—

26.26

Div yield (avg)%

13.82

11.01

8.53

10.54

13.29

15.38

16.08

16.35

13.74

14.88

27.37

15.38

13.78

25.02

Payout ratio%

27.25

26.31

23.69

23.11

21.51

21.71

20.32

23.27

21.80

23.82

24.92

21.80

23.19

991.0

Shares (diluted)M

890.4

898.2

790.6

751.7

690.1

702.9

608.6

603.1

649.7

603.1

960.5

(2.66%)

(3.85%)

10.18

Buyback yield%

22.17

21.18

24.18

26.84

28.13

28.54

26.60

27.80

29.53

31.51

24.87

28.54

27.32

0.444

D/E ratiox

0.839

0.830

0.904

0.934

0.947

1.037

1.193

1.162

1.167

1.122

1.552

1.162

0.992

2.621

Enterprise value€B

4.341

4.417

5.074

5.619

5.853

6.154

6.952

6.873

7.381

7.813

3.061

5.95%

6.58%

11.01

LT debt€B

5.911

5.530

6.070

6.965

7.036

7.853

7.513

6.970

7.421

7.546

1.968

1.41%

2.03%

Peers (US$61.31B)

Cap (US$)

Merck KGaA

72.62B

27.30x

Siemens Healthineers AG

55.82B

22.67x

Fresenius SE & Co. KGaA

33.19B

19.08x

Chugai Pharmaceutical…

71.10B

22.24x

Capital

TTM

10Y

Leveragex

1.155

0.220

0.171

EBIT/Intx

3.112

0.344

0.383

Own earn%

(121.28)

16.85

10.42

Sh yield%

36.43

43.92

42.05

Owners

Insiders/Inst%

12.27

34.01

Short interest%

2.15

SBC / revenue%

2.71

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

2–12

$1 testx

0.9

Incr. ROIC%

Bayer Aktiengesellschaft is a life science company selling prescription drugs, specialty therapeutics, diagnostic imaging, over-the-counter medicines and supplements, and crop protection products, seeds and plant traits. It sells through wholesalers, pharmacies, supermarkets, online and other retailers, hospitals and directly to farmers across Europe, the Middle East, Africa, North America, Asia Pacific and Latin America.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

€12.92B

1.08%

1.00×

Cost of revenue

€9.043B

1.08%

1.00×

Operating expenses

€2.102B

1.11%

1.00×